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a b s t r a c t
Ruptured sinus of Valsalva aneurysm is a rare anomaly and an associated coarctation of
aorta is even rarer. A combination of such defects is traditionally treated surgically. The
surgery is necessarily staged and done through different approaches. We report successful
simultaneous transcatheter treatment of both these defects performed in the same setting
in an acutely ill adult male patient with a good intermediate-term follow-up.
# 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.
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Ruptured sinus of Valsalva aneurysm (RSVA) is a rare, though
well-recognized, clinical entity. It usually presents acutely or
subacutely in adolescence to early adulthood. The aneurysm is
usually congenital in origin and ruptures most commonly into
a right-sided heart chamber. The association of RSVA with
coarctation of aorta (CoA) is extremely rare.1 Stent implanta-
tion for CoA in adults is considered to be an acceptable
alternative to surgery.2 In recent times, transcatheter closure
(TCC) of RSVA is being proposed as a promising alternative to
surgery in suitable patients.3 We describe here interventional
therapy by the transcatheter approach for CoA and RSVA in the
same setting as in an acutely ill patient.* Corresponding author.
E-mail address: jivtesh84@gmail.com (J.S. Pahwa).
http://dx.doi.org/10.1016/j.ihj.2015.09.024
0019-4832/# 2015 Cardiological Society of India. Published by Elsevier2. Case report
A 32-year-old male presented with rapidly progressive
dyspnea over a period of 10 days (New York Heart Association
(NYHA) Class III). On physical examination, he was in
congestive heart failure (CHF) with tachycardia, raised jugular
venous pressure with prominent ‘‘V’’ waves, and bounding
brachial and weak femoral pulses. The blood pressure (BP) in
both arms was 160/50 mm Hg. Auscultation revealed ﬁne rales
over lung bases and a grade IV/VI continuous murmur in lower
left parasternal area. The electrocardiogram showed left
ventricular hypertrophy and radiography was suggestive of
cardiomegaly with increased pulmonary vascularity and rib
notching. Transthoracic echocardiography (TTE) followed by B.V. All rights reserved.
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ﬁrmed the presence of RSVA arising from noncoronary sinus
(NCS) and draining into the right atrium (RA) resulting in a
large left to right shunt, dilatation of all 4 chambers, and mild
grade I/IV aortic regurgitation (AR) with normal biventricular
systolic function. The RSVA measured 11 mm at the aortic end
and 6 mm at the RA exit. Suprasternal view showed severe
postsubclavian CoA with trivial antegrade ﬂow. After stabili-
zation for 3 days, patient was taken up for cardiac catheteri-
zation under general anesthesia with TEE guidance. Before
procedure, an informed consent was obtained and injection
Cefazolin was administered. Right femoral venous and arterial
accesses, and a right radial access, were established. Intrave-
nous Heparin 100 U/kg was given. Cardiac catheterization
demonstrated elevated right heart pressures (right atrial mean
14 mm Hg, right ventricle 40/16 mm Hg, and mean pulmonary
artery pressure 30 mm Hg), elevated left ventricular (150/
20 mm Hg), and ascending aortic pressure (150/60 mm Hg).
The descending aortic pressure was 120/55 mm Hg, with a
peak systolic gradient across the CoA of 30 mm Hg. The CoA
was crossed with the help of 5F Judkins right (JR) coronary
artery diagnostic catheter over a 0.03500 exchange length
straight-tipped glide wire and the catheter was exchanged
with a pigtail catheter for diagnostic angiography in the
descending aorta above the CoA (Fig. 1A, Video 1) and in the
aortic root (Fig. 2A, Video 3). There was severe discrete CoA
beyond left subclavian artery with the isthmus and the
descending aorta at the level of diaphragm measuring
14 mm and 18 mm, respectively. Aortic root angiography
conﬁrmed RSVA arising from NCS and draining into the RA
and mild aortic regurgitation (AR). A 39 mm long Cheatham-
Platinum (CP) stent (NuMed, Hopekinton, NY) was hand-
crimped on a 14 mm  4 mm and 4 cm Z-MEDII (NuMed,
Hopekinton, NY) high pressure balloon and passed through a
long 12F sheath (Cook Inc., Bloomington, IN) over a 0.035 in.
extra-stiff guidewire positioned in the ascending aorta. The
stent was then precisely deployed at CoA site at 4 atm pressure
under angiographic control. The stent was postdilated with a
larger diameter (18 mm) balloon in the poststenotic segmentFig. 1 – A. Descending thoracic aortogram in shallow left oblique
coarctation of aorta with a poststenotic dilatation and B. Arch an
coarctation with a precisely deployed Cheatham-Platinum stentfor better conformation and a good result was conﬁrmed with
angiography. Poststenting, there were no gradients across the
CoA taken with a multitrack catheter over the guidewire.
Supplementary material related to this article can be found,
in the online version, at doi:10.1016/j.ihj.2015.09.024.
The patient tolerated the procedure well and then we
proceeded to perform TCC of RSVA. The RSVA was crossed
from the aortic side using a 5F JR catheter over a 0.035 in.
angled tip glide wire (Terumo Inc., Japan). This was exchanged
for a 300 cm long noodle wire (St. Jude medical, Golden Valley,
MN) that was snared with a 15 mm Amplatz gooseneck snare
(ev3 Europe, Paris, France) from the superior vena cava (Fig. 2B,
Video 4) and exteriorized out of the femoral vein. A stable
arteriovenous wire loop was thus established, over which an
8F Amplatzer delivery sheath (St Jude Medical, St. Paul, MN)
was placed in the ascending aorta. An initial attempt at placing
the largest available (16 mm  14 mm) Amplatzer Duct Occlu-
der (St Jude Medical, St. Paul, MN) failed, as the device slipped
through the defect into the RA. Although we could have used
the radial route, we re-crossed the RSVA from the femoral
route, carefully manipulating the catheter and guidewire
across the stented CoA segment and reestablishing the
arteriovenous wire loop. Under TEE, and ﬂuoroscopic and
angiographic guidance, we were able to position a larger
18 mm  16 mm Lifetech Duct occluder (Shenzhen Lifetech
Scientiﬁc Inc., China) through a 9F SteerEase sheath (Shenzhen
Lifetech Scientiﬁc Inc., China) precisely across the defect
(Fig. 2C, Video 5) taking care to avoid encroachment on the
aortic valve and coronary arteries. After conﬁrming no
increase in AR or any residual shunt on TEE, the device was
released by unscrewing the cable. A postprocedure angiogram
in the aortic arch done through radial route conﬁrmed optimal
device position with complete occlusion of the defect and no
increase in the grade of AR (Fig. 2D, Video 6) and good result
across the stented coarctation segment (Fig. 1B, Video 2).
Supplementary material related to this article can be found,
in the online version, at doi:10.1016/j.ihj.2015.09.024.
The total procedural and ﬂuoroscopy times were 125 min
and 36 min, respectively. In the immediate postprocedure caudal projection showing discrete severe postsubclavian
giogram in the same projection showing relief of the
.
Fig. 2 – A. Aortic root angiography in left anterior oblique with cranial angulation showing RSVA arising from noncoronary
sinus and draining into the right atrium. B. Noodle wire grabbed with a 15 mm Amplatz gooseneck snare to establish the
arteriovenous loop. C. Lifetech Duct occluder (18 mm T 16 mm) with its attached cable positioned through the delivery
sheath at the defect site D. Complete occlusion after duct occluder placement.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 8 1 – s 8 4 S83period, there was signiﬁcant improvement in the patient's
clinical status. There was a hemoglobin drop of 1 g percent, not
requiring any blood transfusion. At discharge three days later,
his BP was normal (120/80 mm Hg) with no signs of heart
failure. He was empirically treated with aspirin (150 mg/day)
and clopidogrel (75 mg/day) for 6 weeks followed by aspirin for
6 months (150 mg/day). At 6-month follow-up, he remained in
NYHA Class I, with well-controlled BP without any anti-
hypertensive medications. Echocardiography revealed the
device to be in situ with no residual shunt, no increase in
the grade of AR, and no signiﬁcant gradients across the stented
CoA.
3. Discussion
Ruptured sinus of Valsalva aneurysm is a very rare entity.
Although coexisting lesions like ventricular septal defect and
AR are commonly described with RSVA, the association of
RSVA and CoA is very rare. In a western series, coexisting CoA
was documented in 4% (1/86)4 while another Asian series
reported a rate of 1 out of 57 RSVA cases.5 Traditionally, a
combination of RSVA and CoA has been treated surgically.However, recently, a combination of RSVA and incidentally
detected CoA were dealt with by surgical correction of RSVA
followed by stenting for a CoA four weeks later.6 We have a
fairly long and large experience of TCC of RSVA including
interventional treatment of coexisting defects.3,7 Hence we
decided to offer interventional treatment of this rare combi-
nation of defects. This case report is unique that both RSVA
and CoA were treated nonsurgically with a single procedure in
an acutely ill patient.
Unruptured aneurysms can remain undetected till they
rupture into one of the chambers of the heart. Also, patients
with isolated CoA may be incidentally detected due to high
arm BP. However, patients with RSVA and a coexisting CoA
present invariably with acute or subacute hemodynamic
decompensation leading to a congested state. The rupture
signiﬁcantly increases the preload acutely while CoA results in
chronic increase in afterload. Various strategies for manage-
ment of these complex anatomical abnormalities include
(i) single-stage surgical, (ii) two-stage surgical, and (iii) staged
hybrid approach. Until recently, two-staged surgical approach
is the most acceptable.8 This contributes to the improvement
of the patient's clinical condition, with the further advantage
of enabling safe perfusion during the second stage of the repair
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) s 8 1 – s 8 4S84(RSVA closure), a few weeks later. As CoA is approached by
lateral thoracotomy and RSVA by median sternotomy, a two-
staged procedure is an acceptable option after a gap of
4–6 weeks.9 The consensus is that single surgical approach
would increase excessively the risk of the procedure. A
prerequisite for a single-stage repair is good biventricular
function.10 In patients with left ventricle (LV) dysfunction,
simultaneous repair is a double-edged sword. Earlier repair of
RSVA can markedly increase afterload, and on the other hand,
earlier repair of CoA can signiﬁcantly decrease peripheral
vascular resistance, decreased perfusion, and aggravation of
heart failure. Hence, in cases with severe LV dysfunction,
staged surgical repair or staged hybrid procedure or staged
transcatheter approach could be a better option.
During transcatheter treatment, the sequence of interven-
tion for the two lesions could be a matter of debate. Since RSVA
is the ‘‘culprit lesion’’, it would seem logical to address it ﬁrst.
However, since the aortic end of the RSVA was large
(measuring 11 mm), a reason for one of the failures in our
previous experience,3 we were not absolutely sure about the
success of TCC. Indeed, after stenting of CoA, during the TCC of
RSVA, we were unsuccessful in our ﬁrst attempt with the 16/
14 mm ADO. It has been our usual practice to use a device size
2–4 mm larger than the defect.11 Upsizing the device may be
necessary at times because of the ﬂimsy (‘‘wind-sock’’-like)
margins of the defect. Hence we prioritized the stenting of CoA
with the initial goal of at least avoiding two different surgeries
through different incisions and minimizing the complexity of
one-stage surgical procedure by dealing with one of them
(CoA) by transcatheter approach. However, this approach of
intervening on CoA ﬁrst increased the ‘‘dwell-time’’ of a large
bore 12F femoral arterial sheath with a potential for arterial
complication. Indeed, there was increased bleeding, albeit
mild, during catheter exchanges through the check valve of
the long 12F sheath, and we had to exchange for another short
12F sheath, after accessing the ascending aorta through the
venous side with the Amplatzer delivery sheath. The radial
access was thus ‘‘well thought’’ not only for controlled
angiography during TCC of RSVA, but also it could have
proven valuable for establishing the arteriovenous loop
without traversing the intervened stented CoA. Poststenting,
there was an immediate signiﬁcant fall in the ascending aortic
pressures, which could have decreased the magnitude of
shunt through RSVA. Patient remained stable and hemody-
namic parameters were under control, so we went ahead with
TCC of RSVA. To the best of our knowledge, simultaneous
transcatheter intervention of both RSVA and CoA has not been
attempted before in an acutely ill patient presenting with heart
failure. In our largest reported series of 20 cases of TCC of
RSVA, we have previously documented successful simulta-
neous transcatheter intervention for both these lesions in a
young female, presenting with secondary hypertension due to
CoA who was incidentally detected to have a small RSVA
requiring the smallest ADO device (6/4 mm).3 In another case
report,12 balloon dilatation of CoA and coil occlusion of a small
RSVA has been staged six weeks apart in a 9-year-old boy,
detected to have a cardiac murmur on routine examination.4. Conclusion
In summary, there has been limited literature on transcatheter
interventional treatment of RSVA with coexisting CoA.
Although technically challenging, our experience suggests
that TCC of RSVA and simultaneous stent implantation for
CoA is a safe and effective alternative to a more complex
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